James Condulis
Stock Analyst at Stifel Nicolaus
(2.91)
# 2,761
Out of 4,983 analysts
59
Total ratings
46.9%
Success rate
4.3%
Average return
Main Sectors:
Top Industries:
Stocks Rated by James Condulis
| Stock | Action | Price Target | Current | Upside | Ratings | Updated | |
|---|---|---|---|---|---|---|---|
| BRVE Braveheart Bio | Reiterated: Buy | $45 | $27.71 | +62.40% | 3 | Sep 9, 2026 | |
| NAMS NewAmsterdam Pharma Company | Reiterated: Buy | $50 | $21.93 | +128.00% | 6 | Sep 8, 2026 | |
| ARWR Arrowhead Pharmaceuticals | Reiterated: Buy | $104 | $67.74 | +53.53% | 3 | Aug 31, 2026 | |
| AMLX Amylyx Pharmaceuticals | Reiterated: Buy | n/a | $33.94 | - | 2 | Aug 18, 2026 | |
| AARD Aardvark Therapeutics | Reiterated: Hold | $6 | $5.53 | +8.50% | 5 | Aug 13, 2026 | |
| EWTX Edgewise Therapeutics | Reiterated: Hold | $36 | $46.94 | -23.31% | 6 | Aug 11, 2026 | |
| CYTK Cytokinetics | Reiterated: Buy | $108 | $69.92 | +54.46% | 16 | Aug 7, 2026 | |
| TECX Tectonic Therapeutic | Reiterated: Buy | $75 | $27.21 | +175.63% | 3 | Aug 7, 2026 | |
| XFOR X4 Pharmaceuticals | Reiterated: Buy | $10 | $3.50 | +185.71% | 2 | Aug 7, 2026 | |
| MIRM Mirum Pharmaceuticals | Reiterated: Buy | $136 | $98.82 | +37.62% | 8 | Aug 6, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgraded: Hold | $25 → $3 | $3.77 | -20.42% | 5 | Jun 2, 2026 |
Braveheart Bio
Sep 9, 2026
Reiterated: Buy
Price Target: $45
Current: $27.71
Upside: +62.40%
NewAmsterdam Pharma Company
Sep 8, 2026
Reiterated: Buy
Price Target: $50
Current: $21.93
Upside: +128.00%
Arrowhead Pharmaceuticals
Aug 31, 2026
Reiterated: Buy
Price Target: $104
Current: $67.74
Upside: +53.53%
Amylyx Pharmaceuticals
Aug 18, 2026
Reiterated: Buy
Price Target: n/a
Current: $33.94
Upside: -
Aardvark Therapeutics
Aug 13, 2026
Reiterated: Hold
Price Target: $6
Current: $5.53
Upside: +8.50%
Edgewise Therapeutics
Aug 11, 2026
Reiterated: Hold
Price Target: $36
Current: $46.94
Upside: -23.31%
Cytokinetics
Aug 7, 2026
Reiterated: Buy
Price Target: $108
Current: $69.92
Upside: +54.46%
Tectonic Therapeutic
Aug 7, 2026
Reiterated: Buy
Price Target: $75
Current: $27.21
Upside: +175.63%
X4 Pharmaceuticals
Aug 7, 2026
Reiterated: Buy
Price Target: $10
Current: $3.50
Upside: +185.71%
Mirum Pharmaceuticals
Aug 6, 2026
Reiterated: Buy
Price Target: $136
Current: $98.82
Upside: +37.62%
Jun 2, 2026
Downgraded: Hold
Price Target: $25 → $3
Current: $3.77
Upside: -20.42%